Questions discussed in this category
How would your recommendation change if the patient has H63 homozygous mutation?
For what duration and is there a preferred anticoagulation agent?
IgG4 manifestations include autoimmune pancreatitis and periaortic soft tissue mass.
For example, in patients who are HbSAg negative, anti-HBc positive and HbSAb negative, does vaccination reduce reactivation risk?
230492225022485198152109720010189061845817674149611275111437920881517601
Papers discussed in this category
Arthritis Rheumatol, 2016 Jan
Blood, 2020 Sep 10
Blood Adv,
Seminars in respiratory and critical care medicine, 2002-12
Clinics in liver disease, 2019-05
Eur J Gastroenterol Hepatol,
Neth J Med,
Semin Respir Crit Care Med, 2020 Aug 10
Blood, 2014 Oct 15
Journal of thrombosis and haemostasis : JTH, 2024 Oct 21
Lancet (London, England), 2019 Mar 22